Celofem 2.5 mg Tablet

Celofem 2.5 mg Tablet contains letrozole 2.5 mg, an aromatase inhibitor used mainly for hormone-sensitive breast cancer in postmenopausal women. It is an oral tablet taken according to the treatment plan prescribed by the oncologist. Letrozole lowers estrogen production, which can help slow the growth of estrogen-dependent cancer cells.

BUY NOW

Celofem 2.5 mg Tablet is used in the treatment of hormone-receptor-positive breast cancer, including early and advanced breast cancer in postmenopausal women. Letrozole works by inhibiting aromatase, an enzyme involved in estrogen production, thereby reducing estrogen levels in the body. It may be prescribed as initial treatment or as continued treatment after tamoxifen, depending on the clinical condition. The dosage and duration should be determined by the treating healthcare professional.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer Celon Laboratories Ltd

Product Also Known As

Celofem 2.5 mg Tablet, Celofem 2.5 Tablet, Celofem Letrozole Tablet, Letrozole 2.5 mg Tablet, Letrozole Breast Cancer Tablet, Letrozole Aromatase Inhibitor Tablet